The reason for the increased serum sFas and sFasL levels in patients with T2DM combined with AD may be that hyperglycemia produces a variety of cytokines, which activate the sFas and sFasL systems, leading to increased expression of sFas and sFasL on the surface of the cells, causing apoptosis of central nervous system cells, and then altering cognitive functions (Nortley et al., 2019). Here, FASLG is linked to type 2 diabetes mellitus.